MMedication Read More Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival TreatmentsDecember 13, 2025 How do you swear in Danish? Our AI chatbots are much too polite to help us out here,…
MMedication Read More High-Dose Wegovy Takes Aim at Lilly’s ZepboundDecember 12, 2025 This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) said its high-dose version of Wegovy has received a…
MMedication Read More Wegovy won’t be in Canadian public drug plans as Novo Nordisk refuses talks – NationalDecember 3, 2025 Negotiations that could have led to coverage of weight-loss drug Wegovy under Canadian public health plans are not…
HHealthcare Read More Which Healthcare Giant Is the Better Bet?November 30, 2025 Novo Nordisk NVO and Pfizer PFE are pharmaceutical giants based in Denmark and the United States, respectively, with strong…
MMedication Read More Ozempic Prices Lowered After Trump DealNovember 17, 2025 Topline Novo Nordisk on Monday lowered the direct-to-consumer prices of its weight loss drug Wegovy and diabetes treatment…
HHealthcare Read More Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants’ Stocks?November 17, 2025 Don’t look now, but the costs of America’s beloved weight loss drugs are about to come down. Way…
HHealthcare Read More Who’s Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?November 13, 2025 Eli Lilly’s GLP-1 drug is now the world’s best-selling drug. Novo Nordisk is struggling with declining market share.…
MMedication Read More Why Weight-Loss Drug Prices Are Falling| Business NewsNovember 11, 2025 President Trump claimed credit Thursday for cutting prices on popular weight-loss drugs by Eli Lilly and Novo Nordisk.…
HHealthcare Read More Mark Cuban Praises TrumpRx Deal With Eli Lilly, Novo NordiskNovember 7, 2025 When President Trump told an audience in October that he hoped to cut the cost of Ozempic down…
MMedication Read More Massive sales for weight loss drugs spur Eli Lilly’s Q3October 31, 2025 As weight loss market rival Novo Nordisk drew headlines for starting a bidding war over a potential $9bn…
MMedication Read More Eli Lilly says weight-loss pill a candidate for speedy approval under new US programOctober 30, 2025 By Mrinalika Roy and Patrick Wingrove (Reuters) -Eli Lilly said on Thursday its experimental weight-loss pill met most…
MMedication Read More How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q3 Results?October 23, 2025 Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…